SIRUKUMAB
Biological
Janssen Research & Development, LLC
Total Payments
$190,669
Transactions
20
Doctors
4
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $190,669 | 20 | 4 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $190,651 | 19 | 100.0% |
| Food and Beverage | $18.68 | 1 | 0.0% |
Top Doctors Receiving Payments for SIRUKUMAB
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $184,508 | 13 |
| , M.D | Pediatric Rheumatology | Cincinnati, OH | $2,700 | 3 |
| , MD | Pediatric Rheumatology | Cincinnati, OH | $2,363 | 2 |
| , MD | Dermatology | Philadelphia, PA | $1,080 | 1 |
| , M.D., PH.D | Diagnostic Radiology | Kentfield, CA | $18.68 | 1 |
Ad
Manufacturing Companies
- Janssen Research & Development, LLC $190,669
Product Information
- Type Biological
- Total Payments $190,669
- Total Doctors 4
- Transactions 20
About SIRUKUMAB
SIRUKUMAB is a biological associated with $190,669 in payments to 4 healthcare providers, recorded across 20 transactions in the CMS Open Payments database. The primary manufacturer is Janssen Research & Development, LLC.
Payment data is available from 2017 to 2017. In 2017, $190,669 was paid across 20 transactions to 4 doctors.
The most common payment nature for SIRUKUMAB is "Consulting Fee" ($190,651, 100.0% of total).